VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 390 filers reported holding VIKING THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $319,445,203 | -52.9% | 6,026,131 | -27.2% | 0.01% | -56.2% |
| Q1 2024 | $678,482,268 | +379.3% | 8,274,174 | +8.8% | 0.02% | +300.0% |
| Q4 2023 | $141,545,187 | +79.3% | 7,605,867 | +6.7% | 0.00% | +100.0% |
| Q3 2023 | $78,939,250 | -29.4% | 7,130,917 | +3.4% | 0.00% | -33.3% |
| Q2 2023 | $111,766,701 | +229.0% | 6,894,923 | +237.9% | 0.00% | +200.0% |
| Q1 2023 | $33,970,629 | +168.5% | 2,040,278 | +51.6% | 0.00% | – |
| Q4 2022 | $12,652,523 | +217.3% | 1,346,013 | -8.2% | 0.00% | – |
| Q3 2022 | $3,987,000 | -3.3% | 1,466,256 | +2.7% | 0.00% | – |
| Q2 2022 | $4,124,000 | -73.3% | 1,427,221 | -72.3% | 0.00% | – |
| Q1 2022 | $15,442,000 | -34.4% | 5,147,461 | +0.5% | 0.00% | -100.0% |
| Q4 2021 | $23,549,000 | -26.8% | 5,119,490 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $32,161,000 | +2.5% | 5,121,133 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $31,388,000 | -6.8% | 5,240,050 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $33,693,000 | +12.6% | 5,327,110 | +0.2% | 0.00% | 0.0% |
| Q4 2020 | $29,931,000 | +9.2% | 5,316,337 | +12.9% | 0.00% | 0.0% |
| Q3 2020 | $27,416,000 | -20.6% | 4,710,752 | -1.6% | 0.00% | 0.0% |
| Q2 2020 | $34,519,000 | +55.4% | 4,787,745 | +0.8% | 0.00% | 0.0% |
| Q1 2020 | $22,218,000 | -41.1% | 4,747,693 | +0.9% | 0.00% | 0.0% |
| Q4 2019 | $37,752,000 | +22.1% | 4,707,261 | +4.7% | 0.00% | 0.0% |
| Q3 2019 | $30,931,000 | -15.2% | 4,495,717 | +2.3% | 0.00% | -50.0% |
| Q2 2019 | $36,482,000 | -10.8% | 4,395,385 | +6.8% | 0.00% | 0.0% |
| Q1 2019 | $40,896,000 | +30.4% | 4,114,466 | +0.4% | 0.00% | 0.0% |
| Q4 2018 | $31,361,000 | -46.3% | 4,099,406 | +22.4% | 0.00% | -33.3% |
| Q3 2018 | $58,355,000 | +109.2% | 3,349,901 | +14.0% | 0.00% | +200.0% |
| Q2 2018 | $27,888,000 | +1595.3% | 2,938,645 | +681.0% | 0.00% | – |
| Q1 2018 | $1,645,000 | +54733.3% | 376,289 | +53426.2% | 0.00% | – |
| Q4 2017 | $3,000 | +200.0% | 703 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 703 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 703 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $2,485,000 | 9.57% |
| Healthcare Value Capital, LLC | 100,000 | $994,000 | 3.83% |
| Sio Capital Management, LLC | 852,160 | $8,470,000 | 2.29% |
| APIS CAPITAL ADVISORS, LLC | 150,000 | $1,491,000 | 1.80% |
| Opaleye Management Inc. | 485,000 | $4,821,000 | 1.34% |
| KNOTT DAVID M | 218,102 | $2,168,000 | 0.86% |
| DAFNA Capital Management LLC | 179,200 | $1,781,000 | 0.77% |
| Rubric Capital Management LP | 810,000 | $8,051,000 | 0.75% |
| Endurant Capital Management LP | 178,448 | $1,774,000 | 0.70% |
| Park West Asset Management LLC | 1,572,507 | $15,631,000 | 0.69% |